XBIO
XENETIC BIOSCIENCES (XBIO) to Acquire Swiss Santersus in Reverse Merger
Xenetic will buy all shares of Santersus AG in a stock-for-stock deal, rename itself Santersus Bio and plans a reverse stock split.
XBIO
Xenetic will buy all shares of Santersus AG in a stock-for-stock deal, rename itself Santersus Bio and plans a reverse stock split.
BULL
Webull's finance chief and director sold 55,000 Class A ordinary shares at $8.9772 apiece on September 14, leaving him with 772,046 shares.
WPRT
Westport Fuel Systems can sell up to US$25 million of common shares to Roth Principal Investments at its own discretion, subject to a 19.99% exchange cap.
NRXP
The FDA reclassified an amendment to NRx's generic application for preservative-free IV ketamine as minor, setting a GDUFA goal date of November 10, 2026.
HIVE
HIVE says combined Bitcoin mining and GPU cloud revenue passed $1 million a day, names Mark Volk revenue chief, and will wind down Swedish mining.
NFE
Founder and chief executive Wesley Edens lifted his direct stake to 957,337 Class A shares after a 208,588-share award and a 28,313-share purchase on September 11.
APO
Apollo-managed funds and KKR have invested equity into a new entity holding Bayer's long-acting reversible contraceptives business, with Bayer keeping majority control.
ROST
CEO James Grant Conroy sold 49,205 Ross Stores shares on the open market at about $229.48 apiece, leaving him with 134,349 shares.
S
Chief executive Tomer Weingarten sold 114,890 Class A shares at $19.8899 apiece after converting 57,941 shares, a Form 4 shows.
Regulatory
Iceland's Ásar hf. says the competition regulator's preliminary view is that remedies are needed for its purchases of Öryggismiðstöð Íslands and Opin kerfi.
UBER
Uber agreed to sell €4.5 billion of senior notes maturing between 2029 and 2046, with coupons ranging from 3.750% to 5.250%.
SABR
Sabre's financing subsidiary is marketing $1.1 billion of senior secured notes to repay existing debt, including 11.125% secured notes due 2029.